Ocumension Therapeutics (FRA:5DG)

Ocumension Therapeutics Employees

Ocumension Therapeutics had 505 employees as of June 30, 2025. The number of employees increased by 16 or 3.27% since the number was reported on December 31, 2024.

• Employees: 505
• Change: 16
• Growth: 3.27%
• Revenue / Employee: €127,974
• Profits / Employee: €58,667
• Market Cap: 649.42M

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Jun 30, 2025	505	16	3.27%
Dec 31, 2024	489	45	10.14%
Dec 31, 2023	444	46	11.56%
Dec 31, 2022	398	262	192.65%
Dec 31, 2020	136	95	231.71%